Brief: Crescita Therapeutics Inc Reports Quarterly EPS Of $0.06
15/03/2023 11:40
March 15 (Reuters) - Crescita Therapeutics Inc CTX.TO :
* CRESCITA REPORTS Q4 AND FISCAL 2022 RESULTS
* CRESCITA THERAPEUTICS INC Q4 REVENUE C$6030 VERSUS C$7562
* CRESCITA THERAPEUTICS INC - QTRLY EPS $0.06
* CRESCITA THERAPEUTICS INC - ALL AMOUNTS PRESENTED ARE IN
THOUSANDS OF CANADIAN DOLLARS
Source text for Eikon: ID:nBw4WYWjja
Further company coverage: CTX.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Crescita Therapeutics
See all newsBrief: Crescita Therapeutics Obtains Shareholder Approval To Be Acquired By Clinactiv Holdings
Canada's Crescita Q1 revenue rises on manufacturing growth
Canada's Crescita Q4 revenue falls on prior-year one-time reimbursement
Brief: Crescita Reports Q4 And Fiscal 2025 Results
Brief: Crescita Announces Definitive Agreement To Be Acquired By Clinactiv Holdings In An All-Cash Transaction At A Significant Premium